Literature DB >> 15764424

Quantitative drug levels in stimulant psychosis: relationship to symptom severity, catecholamines and hyperkinesia.

Steven L Batki1, Debra S Harris.   

Abstract

To examine the relationship between quantitative stimulant drug levels, catecholamines, and psychotic symptoms, nineteen patients in a psychiatric emergency service with a diagnosis of amphetamine- or cocaine-induced psychosis were interviewed, and plasma and urine were collected for quantitative assays of stimulant drug and catecholamine metabolite levels. Methamphetamine or amphetamine levels were related to several psychopathology scores and the global hyperkinesia rating. HVA levels were related to global hyperkinesia but not to psychopathology ratings. Although many other factors such as sensitization may play a role, intensity of stimulant-induced psychotic symptoms and stereotypies appears to be at least in part dose-related.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15764424     DOI: 10.1080/10550490490512834

Source DB:  PubMed          Journal:  Am J Addict        ISSN: 1055-0496


  17 in total

1.  A comparison of psychotic symptoms in subjects with methamphetamine versus cocaine dependence.

Authors:  Peter D Alexander; Kristina M Gicas; Taylor S Willi; Clara N Kim; Veronika Boyeva; Ric M Procyshyn; Geoff N Smith; Allen E Thornton; William J Panenka; Andrea A Jones; Fidel Vila-Rodriguez; Donna J Lang; G William MacEwan; William G Honer; Alasdair M Barr
Journal:  Psychopharmacology (Berl)       Date:  2017-02-11       Impact factor: 4.530

2.  Mechanisms of acute cocaine toxicity.

Authors:  Kennon Heard; Robert Palmer; Nancy R Zahniser
Journal:  Open Pharmacol J       Date:  2008

3.  Decreased Expression of Plasma MicroRNA in Patients with Methamphetamine (MA) Use Disorder.

Authors:  Yan Zhao; Kai Zhang; Haifeng Jiang; Jiang Du; Zong Na; Wei Hao; Shunying Yu; Min Zhao
Journal:  J Neuroimmune Pharmacol       Date:  2016-04-23       Impact factor: 4.147

Review 4.  Methamphetamine psychosis: epidemiology and management.

Authors:  Suzette Glasner-Edwards; Larissa J Mooney
Journal:  CNS Drugs       Date:  2014-12       Impact factor: 5.749

5.  Methamphetamine and paranoia: the methamphetamine experience questionnaire.

Authors:  Martin H Leamon; Keith Flower; Ruth E Salo; Thomas E Nordahl; Henry R Kranzler; Gantt P Galloway
Journal:  Am J Addict       Date:  2010 Mar-Apr

6.  Predictors of methamphetamine psychosis: history of ADHD-relevant childhood behaviors and drug exposure.

Authors:  Ruth Salo; Catherine Fassbender; Ana-Maria Iosif; Stefan Ursu; Martin H Leamon; Cameron Carter
Journal:  Psychiatry Res       Date:  2013-07-26       Impact factor: 3.222

Review 7.  Treatment for amphetamine psychosis.

Authors:  Steven J Shoptaw; Uyen Kao; Walter Ling
Journal:  Cochrane Database Syst Rev       Date:  2009-01-21

Review 8.  Methamphetamine-associated psychosis.

Authors:  Kathleen M Grant; Tricia D LeVan; Sandra M Wells; Ming Li; Scott F Stoltenberg; Howard E Gendelman; Gustavo Carlo; Rick A Bevins
Journal:  J Neuroimmune Pharmacol       Date:  2011-07-05       Impact factor: 4.147

9.  Differential patterns of blood oxygenation in the prefrontal cortex between patients with methamphetamine-induced psychosis and schizophrenia.

Authors:  Kazuhiko Yamamuro; Manabu Makinodan; Sohei Kimoto; Naoko Kishimoto; Tsubasa Morimoto; Michihiro Toritsuka; Kiwamu Matsuoka; Yoshihiro Takebayashi; Tomoyo Takata; Masato Takahashi; Yoshinori Tanimura; Yosuke Nishihata; Yasuhiro Matsuda; Toyosaku Ota; Hiroki Yoshino; Junzo Iida; Toshifumi Kishimoto
Journal:  Sci Rep       Date:  2015-07-16       Impact factor: 4.379

10.  Methamphetamine-associated psychosis: a new health challenge in Iran.

Authors:  Zahra Alam Mehrjerdi; Alasdair M Barr; Alireza Noroozi
Journal:  Daru       Date:  2013-04-11       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.